Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis

Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis

Abstract Cardiovascular (CV) disease is the main cause of mortality in axial spondyloarthritis (axSpA). CV risk is enhanced by dysregulation of adipokines. Low omentin levels were associated with metabolic dysfunction and CV disease in conditions different from axSpA. Accordingly, we evaluated the g...

Full description

Bibliographic Details
Main Authors: Fernanda Genre, Javier Rueda-Gotor, Sara Remuzgo-Martínez, Verónica Pulito-Cueto, Alfonso Corrales, Verónica Mijares, Leticia Lera-Gómez, Virginia Portilla, Rosa Expósito, Cristina Mata, Ricardo Blanco, Javier Llorca, Vanesa Hernández-Hernández, Esther Vicente, Cristina Fernández-Carballido, María Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, Carlos Rodríguez-Lozano, Oreste Gualillo, Juan Carlos Quevedo-Abeledo, Santos Castañeda, Iván Ferraz-Amaro, Raquel López-Mejías, Miguel Á. González-Gay
Format: Article
Language:English
Published: Nature Publishing Group 2020-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-66816-x

Internet

https://doi.org/10.1038/s41598-020-66816-x

Similar Items